α,α-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells

被引:17
|
作者
Wang, M
Xu, ZD
Tu, PF
Yu, XL
Xiao, SL
Yang, M [1 ]
机构
[1] Peking Univ, Natl Res Lab Nat & Biomimet Drugs, Beijing 100083, Peoples R China
[2] Heibei Univ Sci & Technol, Dept Pharmaceut Chem, Shijiazhuang 050018, Peoples R China
基金
中国国家自然科学基金;
关键词
alpha; alpha-trehalose; guanidino groups; Tat-TAR interaction;
D O I
10.1016/j.bmcl.2004.02.073
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Replication of HIV-1 requires specific interactions of Tat protein with TAR RNA. Disruption of Tat TAR RNA interaction could inhibit HIV-1 replication. Here four target compounds were designed and synthesized to bind to TAR RNA for blocking the interaction of Tat-TAR RNA. The core molecule 6,6'-diamino-6,6'-dideoxy-alpha,alpha-trehalose was obtained from selective bromination of, alpha,alpha-trehalose at C-6,6', followed by acetylation, azide displacement, deacetylation, and reduction. Coupling of the core molecule with the protected amino acid, then deprotection and guanidinylation generated the novel alpha,alpha-trehalose derivatives. Their abilities to inhibit Tat-TAR RNA interaction in human cells were determined by a Tat-dependent HIV-1 LTR-driven CAT assays. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2585 / 2588
页数:4
相关论文
共 50 条
  • [21] In silico Analyses of Subtype Specific HIV-1 Tat-TAR RNA Interaction Reveals the Structural Determinants for Viral Activity
    Ronsard, Larance
    Rai, Tripti
    Rai, Devesh
    Ramachandran, Vishnampettai G.
    Banerjea, Akhil C.
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [22] A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition
    Hamy, F
    Brondani, V
    Flörsheimer, A
    Stark, W
    Blommers, MJJ
    Klimkait, T
    BIOCHEMISTRY, 1998, 37 (15) : 5086 - 5095
  • [23] Molecular modeling of the HIV-1 tat protein - TAR RNA complex and the design of an inhibitor of the Tat/TAR RNA interaction
    Rao, GS
    Siddiqui, MI
    Arora, S
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2000, : 65 - 74
  • [24] CHARACTERIZATION OF RECOMBINANT HIV-1 TAT AND ITS INTERACTION WITH TAR RNA
    SLICE, LW
    CODNER, E
    ANTELMAN, D
    HOLLY, M
    WEGRZYNSKI, B
    WANG, J
    TOOME, V
    HSU, MC
    NALIN, CM
    BIOCHEMISTRY, 1992, 31 (48) : 12062 - 12068
  • [25] Design, synthesis, and biological activity of a cyclic peptide: An inhibitor of HIV-1 Tat-TAR interactions in human cells
    Tamilarasu, N
    Huq, I
    Rana, TM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (09) : 971 - 974
  • [26] The folding competence of HIV-1 Tat mediated by interaction with TAR RNA
    Kim, Jung Min
    Choi, Hee Sun
    Seong, Baik Lin
    RNA BIOLOGY, 2017, 14 (07) : 926 - 937
  • [27] An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication
    Hamy, F.
    Felder, E. R.
    Heizmann, G.
    Lazdins, J.
    Proceedings of the National Academy of Sciences of the United States of America, 94 (08):
  • [28] An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication
    Hamy, F
    Felder, ER
    Heizmann, G
    Lazdins, J
    AboulEla, F
    Varani, G
    Karn, J
    Klimkait, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 3548 - 3553
  • [29] Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving
    Huq, I
    Rana, TM
    BIOCHEMISTRY, 1997, 36 (41) : 12592 - 12599
  • [30] HIV-1 Tat amino acid residues that influence Tat-TAR binding affinity: a scoping review
    Gotora, Piwai Terry
    van der Sluis, Rencia
    Williams, Monray Edward
    BMC INFECTIOUS DISEASES, 2023, 23 (01)